Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register using a personal email and password.Have you forgotten your password?
Repository logo
    Info Pages
    Content PolicyCopyright & Access InfoDepositing to MRODeposit LicenseDeposit License SummaryFile FormatsTheses FAQDoctoral Thesis Deposit
  • Communities & Collections
  • All of MRO
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register using a personal email and password.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Manning, Tom"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    Development of a reproducible transcriptomics variant calling workflow and its application to colorectal cancer : a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Genetics at Massey University, Albany, New Zealand
    (Massey University, 2020) Manning, Tom
    Colorectal cancer (CRC) is one of the most common cancers worldwide. It has some of the highest rates in New Zealand, exacerbated by short-comings in available diagnostic tools and survival discrepancies between Maori and non-Maori demographics. In this project, a bioinformatics workflow was developed to make “high confidence” single nucleotide polymorphism (SNP) variant calls from transcriptomics/RNA-seq data. While calling variants from whole genome and exome sequencing is common, standard workflows for calling variants from RNA-seq data do not exist. Here, we aimed to use two common RNA-seq pre-processing methods which we then complemented with an ensemble of variant calling tools, improving confidence in any variants called. We then applied this pipeline to two independent CRC datasets with the hope that those variant calls could improve our understanding of the disease, one of the most significant aggregators of cancer-related mortality. Variant calls were made including those with clinical implications, such as the same KRAS gene variant being called between both geographically distinct populations. Multiple “novel” variants, or those lacking clinically significant annotations, were also obtained for known oncogenic targets (e.g. MAPK1 and AKT1). RNA-seq variant calling remains problematic. The results of this study have provided us with some direction and considerations for future work, such as including normal samples to better distinguish between germline and somatic variants, permit the use of more somatic variant calling tools, etc. Future work is also needed to understand how or if those novel variant calls could improve our understanding of CRC

Copyright © Massey University  |  DSpace software copyright © 2002-2025 LYRASIS

  • Contact Us
  • Copyright Take Down Request
  • Massey University Privacy Statement
  • Cookie settings